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Syphilis transmitted from mother to 
child is second only to malaria as a 
leading cause of preventable stillbirth.1 
An estimated 930 000 pregnant women 
experience 350 000 adverse pregnancy 
outcomes annually due to syphilis. 
Over half of these affected pregnancies 
end in stillbirth or neonatal death.2 
Elimination of mother-to-child trans-
mission of syphilis relies on reducing 
the background prevalence of syphilis 
in pregnant women as well as within 
general populations. Screening and 
treatment of high-risk populations and 
pregnant women are critical strate-
gies that can rapidly reduce morbidity 
and mortality related to this infection. 
However, while countries frequently 
have well-resourced programmes for 
human immunodeficiency virus (HIV) 
prevention and care, syphilis control 
is seldom centralized and often falls 
within the responsibilities, but outside 
the priorities, of HIV programmes or 
antenatal care. Advocacy, policy imple-
mentation and resource allocation for 
syphilis testing and treatment are often 
deficient, particularly in countries with 
high syphilis burden.3
The World Health Organization 
(WHO) strategy for the elimination 
of congenital syphilis prioritized com-
mitment and advocacy at the highest 
levels, alongside promoting increased 
access to and quality of maternal and 
newborn health services, improved cov-
erage of syphilis testing and treatment 
in pregnancy and ongoing surveillance, 
monitoring and evaluation of targets.4 
In 2014, regional and country-led ini-
tiatives as well as encouragement by 
external partners led WHO to promote 
integrating programmes for dual elimi-
nation of mother-to-child transmission 
of both HIV and syphilis, recognizing 
that harmonized approaches improved 
efficiency and quality of maternal and 
newborn health services and improved 
health outcomes for mothers and infants. 
The resulting WHO global guidance on 
elimination of mother-to-child transmis-
sion of HIV and syphilis set correspond-
ing process criteria for country validation 
of (i) at least 95% coverage of antenatal 
care; (ii) 95% testing coverage of preg-
nant women for HIV and syphilis; and 
(iii) 95% treatment coverage for those 
pregnant women testing positive for HIV 
or syphilis.5 In addition to antenatal-care-
specific targets, the global guidance also 
calls for enhanced access for the general 
population to syphilis prevention and 
control interventions.
Integration of syphilis prevention 
with HIV control programmes offers 
the opportunity to expand coverage of 
syphilis testing and treatment among 
populations at risk for both infections, 
particularly among pregnant women, 
who bear the highest burden of adverse 
outcomes. Aligning elimination efforts 
may also contribute to strengthening 
the health system and saving costs.6 For 
example, in China, syphilis was low on 
the national policy agenda due to lim-
ited external support, uncoordinated 
domestic initiatives, lack of awareness 
of the problem and its solutions among 
policymakers and negative issue framing 
leading to stigma and discrimination.7 
Since 2010, in China, syphilis screen-
ing and treatment has been gradually 
incorporated into HIV counselling and 
testing sites,8 and integrated antenatal 
HIV and syphilis interventions have be-
come a normal part of routine antenatal 
care.9 Leveraging the well-established 
platform of HIV control, including 
health facilities, staff, supplies and data 
reporting mechanisms has proven effec-
tive not only in enhancing political com-
mitment to combat syphilis but also in 
mobilizing resources for the expansion 
of syphilis testing and treatment. Ac-
cording to data from the National Cen-
ter for Women and Children’s Health in 
China, the annual number of pregnant 
women tested for syphilis increased rap-
idly, and by 2013 over 96% of antenatal 
care attendees in areas covered by the 
integrated programme were tested for 
syphilis and HIV.9
New technology has increased the 
feasibility of integrated testing. For 
example, the development of rapid 
dual HIV/syphilis test kits has enabled 
additional syphilis intervention oppor-
tunities within clinical settings. This kit 
allows simultaneous testing for both 
infections on a single cartridge. A sys-
tematic review has shown that the field 
performance of rapid dual HIV/syphilis 
tests is comparative to laboratory refer-
ence testing.10 The added utility and 
feasibility of a single platform for testing 
of multiple infections makes these tests 
attractive for use among populations 
recommended for routine screening for 
both infections. WHO recognizes dual 
HIV/syphilis (multiplex) point-of-care 
diagnostics as an option for HIV test-
ing and has released interim guidance 
on using and interpreting these tests, 
pending a WHO-approved algorithm.11 
In some areas, HIV resources may be 
leveraged to purchase rapid dual HIV/
syphilis test kits.
While improved diagnostic tools 
may improve efficiency and testing 
coverage, securing and maintaining 
strong political commitment is also 
critical to programme success. China 
has succeeded in increasing syphilis test-
ing and treatment for pregnant women 
nationally, and for high-risk groups in 
some areas, by strategically integrating 
syphilis control with HIV – an issue 
that receives both political attention 
and resources in the country.8,9,12 Such 
integration may be reproducible in 
other countries, particularly those where 
syphilis burden is high. However, inte-
gration cannot rely on technology alone. 
As the experience of China has shown, 
elimination of mother-to-child trans-
mission of both HIV and syphilis relies 
upon the commitment of policy-makers 
and associated resource allocation, 
both of which are likely to be driven by 
sustained advocacy to promote compre-
hensive and effective antenatal care. ■
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